Medical and Pharmaceutical Scribe Therapeutics develops one-time cholesterol treatment without permanent gene editing Scribe instead wants one treatment to keep PCSK9 switched down for an extended period Joseph Morton20 hours ago
Medical and Pharmaceutical Novartis advances actinium-based cancer drug after promising trial data Researchers presented the findings at the annual meeting of the American Society of Clinical Oncology in Chicago Joseph MortonJune 1, 2026
AI and Autonomy AI-designed drugs near human trials as AlphaFold enters clinical phase Isomorphic Labs launched in 2021 as a unit of Alphabet Inc Joseph MortonApril 29, 2026